| Issue Date | Title | Author(s) |
| 2020-11 | Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis | Mehta, M; Prasher, P; Sharma, M; Shastri, MD; Khurana, N; Vyas, M; Dureja, H; Gupta, G; Anand, K; Satija, S; Chellappan, DK; Dua, K |
| 2023-12 | Corrigendum to "Pharmacological evaluation of bromelain in mouse model of Alzheimer's disease" [NeuroToxicology 90 (2022) 19-34]. | Kumar, R; Kumar, R; Sharma, N; Khurana, N; Singh, SK; Satija, S; Mehta, M; Vyas, M |
| - | Enhancing the oral bioavailability of fisetin: polysaccharide-based self nano-emulsifying spheroids for colon-targeted delivery | Gunjal, P; Vishwas, S; Kumar, R; Bashir, B; Kumar, B; Khurana, N; Gulati, M; Gupta, G; Prasher, P; Kumbhar, P; Disouza, J; Kuppusamy, G; Mohammed, Y; Dureja, H; Dua, K; Singh, SK |
| 2024-12-01 | Gamma Oryzanol: A natural compound with potential for treating polycystic ovary syndrome | Chakraborty, S; Khurana, N; Kaur, J; Mehta, M; Sharma, N |
| 2021 | Hypoxia-Inducible Factor (HIF): Fuel for Cancer Progression. | Satija, S; Kaur, H; Tambuwala, MM; Sharma, P; Vyas, M; Khurana, N; Sharma, N; Bakshi, HA; Charbe, NB; Zacconi, FC; Aljabali, AA; Nammi, S; Dureja, H; Singh, TG; Gupta, G; Dhanjal, DS; Dua, K; Chellappan, DK; Mehta, M |
| - | Improved neuroprotective activity of Fisetin through SNEDDS in ameliorating the behavioral alterations produced in rotenone-induced Parkinson’s model | Kumar, R; Kumar, R; Khurana, N; Singh, SK; Khurana, S; Verma, S; Sharma, N; Vyas, M; Dua, K; Khursheed, R; Awasthi, A; Vishwas, S |
| 2019-05-01 | Interactions with the macrophages: An emerging targeted approach using novel drug delivery systems in respiratory diseases | Mehta, M; Deeksha; Sharma, N; Vyas, M; Khurana, N; Maurya, PK; Singh, H; Andreoli de Jesus, TP; Dureja, H; Chellappan, DK; Gupta, G; Wadhwa, R; Collet, T; Hansbro, PM; Dua, K; Satija, S |
| 2021-10-01 | Nanotechnology based advanced therapeutic strategies for targeting interleukins in chronic respiratory diseases. | Hussain, MS; Sharma, P; Dhanjal, DS; Khurana, N; Vyas, M; Sharma, N; Mehta, M; Tambuwala, MM; Satija, S; Sohal, SS; Oliver, BGG; Sharma, HS |
| 2020-01-01 | Oxidative stress in neurology and in neurodegenerative processes | Gupta, G; Pathak, S; Rawat, S; Mishra, A; Singh, Y; Mehta, M; Satija, S; Khurana, N; De Jesus Andreoli Pinto, T; Shukla, S; Pabreja, K; Chellappan, DK |
| 2021 | Perfluorocarbons Therapeutics in Modern Cancer Nanotechnology for Hypoxiainduced Anti-tumor Therapy. | Satija, S; Sharma, P; Kaur, H; Dhanjal, DS; Chopra, RS; Khurana, N; Vyas, M; Sharma, N; Tambuwala, MM; Bakshi, HA; Charbe, NB; Zacconi, FC; Chellappan, DK; Dua, K; Mehta, M |
| 2022-05 | Pharmacological evaluation of bromelain in mouse model of Alzheimer's disease. | Kumar, R; Kumar, R; Sharma, N; Khurana, N; Singh, SK; Satija, S; Mehta, M; Vyas, M |
| 2020-11-06 | Potential Anti-epileptic Phytoconstituents: An Updated Review. | Kaur, J; Famta, P; Famta, M; Mehta, M; Satija, S; Sharma, N; Vyas, M; Khatik, GL; Chellappan, DK; Dua, K; Khurana, N |
| 2019-09-01 | The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress | Dua, K; Wadhwa, R; Singhvi, G; Rapalli, V; Shukla, SD; Shastri, MD; Gupta, G; Satija, S; Mehta, M; Khurana, N; Awasthi, R; Maurya, PK; Thangavelu, L; Rajeshkumar, S; Tambuwala, MM; Collet, T; Hansbro, PM; Chellappan, DK |
| 2021-10-15 | Protein and peptide delivery to lungs by using advanced targeted drug delivery. | Chellappan, DK; Prasher, P; Saravanan, V; Vern Yee, VS; Wen Chi, WC; Wong, JW; Wong, JK; Wong, JT; Wan, W; Chellian, J; Molugulu, N; Prabu, SL; Ibrahim, R; Darmarajan, T; Candasamy, M; Singh, PK; Mishra, V; Khurana, N; Shastri, MD; Satija, S; Zacconi, FC; Chakraborty, A; Mehta, M; Gupta, PK; Dureja, H; Gulati, M; Singh, SK; Gupta, G; Jha, NK; George Oliver, BG; Dua, K |
| 2019-01 | Recent Developments in Alpha-Glucosidase Inhibitors for Management of Type-2 Diabetes: An Update. | Usman, B; Sharma, N; Satija, S; Mehta, M; Vyas, M; Khatik, GL; Khurana, N; Hansbro, PM; Williams, K; Dua, K |
| 2021-02 | Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities. | Lee, L-Y; Hew, GSY; Meenu,; Shukla, SD; Satija, S; Khurana, N; Anand, K; Dureja, H; Singh, SK; Mishra, V; Singh, PK; Gulati, M; Prasher, P; Aljabali, AAA; Tambuwala, MM; Thangavelu, L; Panneerselvam, J; Gupta, G; Zacconi, FC; Shastri, M; Jha, NK; Xenaki, D; MacLoughlin, R; Oliver, BG; Chellappan, DK; Dua, K |
